SCHEMBL3377280

SCHEMBL3377280

OB(OCl)c1cccc(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 6/20 0.38
MGLL Q99685 2/20 0.37
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ACHE P22303 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
CA14 Q9ULX7 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
NFE2L2 Q16236 2/20 0.34
PARP1 P09874 1/20 0.34
ESR2 Q92731 1/20 0.34
IDO1 P14902 1/20 0.33
AGXT P21549 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29582240 0.80 ENPP2 (0.46) ENPP2MGLLCES2CES1KDM4E
SCHEMBL28799132 0.80 IDO1 (0.41) ENPP2MGLLCES2CES1KDM4E
SCHEMBL16247947 0.80 ENPP2 (0.46) ENPP2MGLLCES2CES1KDM4E
SCHEMBL28258396 0.79 CA12 (0.36) CES2CES1
SCHEMBL29547555 0.78 ENPP2 (0.58) ENPP2MGLLCES2CES1KDM4E
SCHEMBL4933 0.78 ENPP2 (0.58) ENPP2MGLLCES2CES1KDM4E
SCHEMBL17667917 0.78 ENPP2 (0.59) ENPP2ALDH1A1ACHECA6CA5A
SCHEMBL22500900 0.77 ENPP2 (0.43) ENPP2MGLLCES2CES1KDM4E
SCHEMBL2320318 0.76 ACHE (0.42) ENPP2ALDH1A1ACHEPARP1IDO1
SCHEMBL13989005 0.76 ALDH1A1 (0.61) ENPP2KDM4EALDH1A1CA4CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108558871-A Novel tricyclic compound as anticancer agent 百时美施贵宝公司 2018-09-21 CN disclosed
CN-108368083-A heteroaryl compounds and their use as therapeutic agents 东亚首希控股股份有限公司 2018-08-03 CN disclosed
CN-108349989-A Pyrano bipyridine compound 卫材R&D管理有限公司 2018-07-31 CN disclosed
CN-105764901-B As for treating pyrido [4,3-B] pyrazine -2- formamides of the neurogenic medicine of neurodegenerative disease 豪夫迈·罗氏有限公司 2018-06-22 CN disclosed
CN-106029663-B Tricyclic compounds as anticancer agents 百时美施贵宝公司 2018-06-01 CN disclosed
CN-107428744-A Novel heterocyclic compounds and its application in medicine and cosmetics 盖尔德马研究及发展公司 2017-12-01 CN disclosed
CN-105593221-B Compound with somatostatin receptor agonistic activity and pharmaceutical use thereof 小野药品工业株式会社 2017-09-22 CN disclosed
CN-106995415-A It is used as the fusion benzo oxygen azepine * ketone of ion channel modulators 吉利德科学公司 2017-08-01 CN disclosed
CN-104245674-B Phenyl-tetrahydroisoquinoline derivatives 霍夫曼-拉罗奇有限公司 2017-07-11 CN disclosed
CN-104271571-B Tetrazolinone compound and use thereof 住友化学株式会社 2017-07-07 CN disclosed
CN-104245689-B Terazololine-one compound and its purposes as insecticide 住友化学株式会社 2017-06-06 CN disclosed
CN-106794364-A Substituted 4-phenylpiperidines, their preparation and use 哥伦比亚大学董事会 2017-05-31 CN disclosed
WO-2010056527-A2 FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS GILEAD PALO ALTO, INC. (US) 2010-05-20 WO disclosed